Home

Business

Medical Business

Stemlink’s Business

Veterinary Technology

Introduction of our subsidiary’s, Stemlink’s business

Veterinary Technology

Let me introduce you to Stemcell Holdings’ innovative animal regenerative medicine business.

Our wholly-owned subsidiary, Stemlink K.K. (“Stemlink”), provides cutting-edge regenerative medicine technology aimed at improving the health and happiness of pets.

Case Study

We are working in close cooperation with veterinary hospitals in Japan to treat animals using our medical technologies, including exosomes, and to analyze data for further improvements. Below are just a few examples (click to play video);

Exosome Case Study: Yorkshire Terrier, 12y

Diagnosis: Epilepsy, Neurological disorder, Heart failure

Exosome Case Study: Japanese Shiba, 15y

Diagnosis: Hepatic failure, Subacute pancreatitis

Exosome Case Study: Ferret, 3y

Diagnosis: Intervertebral disc herniation, Unable to walk

Exosome Case Study: Dachshund, 11y

Diagnosis: Intervertebral disc herniation

Key features

Advanced
Veterinary Services

Stemlink addresses various animal diseases and injuries that were difficult to treat with conventional methods, using the latest regenerative medicine technologies.

Top-class Track Record
in Japan

Stemlink have built a strong network with veterinary hospitals nationwide and have accumulated numerous treatment cases. This experience validates the reliability and effectiveness of their technology.

Meeting Increased
Pet Demand

With the recent surge in pet ownership, the need for advanced veterinary services has also expanded. Stem Link’s technology plays a crucial role in meeting this demand.

Future-oriented
Research and Development

While currently focused on the pet medical market, Stemlink’s R&D efforts also consider potential applications in human medicine in the future.

Expanding Business
Development

We aim to expand into new regions and international markets, leveraging our established business model.

Unique Competitive
Advantage

Our advanced technology and extensive clinical experience provide us with strengths that are not easily replicable by competitors.

Stemlink’s animal regenerative medicine business brings new hope to pets and their owners while pioneering the future of veterinary medicine. Our mission is to contribute to the better lives of animals and the happiness of their owners.